PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.\', \'Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. L.Lee.2@bham.ac.uk.\', \'Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.\', \'Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.\', \'Clatterbridge Cancer Centre, Bebington, Wirral, CH63 4JY, UK.\', \'Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GL, UK.\', \'Leeds Cancer Centre, St James\'s University Hospital, Leeds, LS9 7TF, UK.\', \'School of Biomedical Engineering and Imaging Sciences, King\'s College London, London, SE1 7EH, UK.\', \'UCL Cancer Institute, University College London, London, WC1E 6BT, UK.\', \'Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, EH4 2XR, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41416-020-0930-7
?:hasPublicationType
?:journal
  • British journal of cancer
is ?:pmid of
?:pmid
?:pmid
  • 32546835
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.89
?:rankingScore_hIndex
  • 204
?:title
  • Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32546835>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32546835>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all